SHP-627 | m-entrepreneurship.com

Product Name :
SHP-627

Search keywords :
FT001

drugId :
null

Target Vo:
Platelet-derived growth factor subunit B

Target Vo Short Name :
PDGFB

Moa_Name:
Platelet-derived growth factor subunit A inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shire Pharmaceuticals

Active Company_Name :
Catalent Maryland Inc

Active Indication_Name:
Retinal Degeneration

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HOPX Antibody
HSP70 Antibody (YA728)
Muscarinic Acetylcholine receptor M3 Antibody: Muscarinic Acetylcholine receptor M3 Antibody is an unconjugated, approximately 65 kDa, rabbit-derived, anti-Muscarinic Acetylcholine receptor M3 polyclonal antibody. Muscarinic Acetylcholine receptor M3 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, and predicted: mouse, rat background without labeling.

Author: Betaine hydrochloride

Related Posts